GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GelStat Corp (OTCPK:GSAC) » Definitions » Construction In Progress

GelStat (GelStat) Construction In Progress : $0.00 Mil (As of Dec. 2008)


View and export this data going back to 1996. Start your Free Trial

What is GelStat Construction In Progress?


GelStat Construction In Progress Historical Data

The historical data trend for GelStat's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GelStat Construction In Progress Chart

GelStat Annual Data
Trend Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

GelStat Quarterly Data
Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

GelStat Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


GelStat (GelStat) Business Description

Traded in Other Exchanges
N/A
Address
333 SE 2nd Avenue, Suite 2000, Miami, FL, USA, 33131
GelStat Corp is a consumer healthcare company operating in the US. It is engaged in the development and marketing of over-the-counter (OTC) and other non-prescription consumer healthcare products. The company's lead product is Gelstat Migraine, which is a patented OTC homeopathic drug for use as a first-line, acute treatment for migraine and migraine-like headaches. The Gelstat Migraine is developed to provide acute relief from headache pain as well as other symptoms associated with a migraine. The other products of the company include CHEWS 2 LOSE, which is a diet aide in the form of an all-natural appetite suppressant gum; All Natural Speed which targets specific quick-fix energy user groups; and GelStat Sleep, which provides relief from sleep disorders and their associated symptoms.
Executives
Adrian Graham Goldfarb director 7660 CENTURION PARKWAY, SUITE 100, JACKSONVILLE FL 32256
Donald Miller director, officer: Chief Financial Officer
Garry N Lowenthal officer: Chief Financial Officer 2551 38TH AVENUE NE, STE 135, MINNEAPOLIS MN 55421

GelStat (GelStat) Headlines

No Headlines